This is the authors' abstract. We don't add key points for this paper.
MXene, enabling efficient aptamer immobilization and signal enhancement. These findings highlight the potential of the developed aptasensor as a non-invasive, reliable, and cost-effective platform for early HER-2 detection, paving the way for improved breast cancer diagnosis and monitoring.
No takes yet. Share an insight, caveat, or question.
Rawat et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: